Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
The Future of Dermatology: Lasers, AI, and Molecular Treatments
Description
The speaker reflects on the future of dermatology as part of a broader medical revolution driven by molecular therapies, cells, genes, AI, imaging, and advanced energy devices. He argues dermatology is already leading in biologics and targeted pathways, while therapies like CRISPR and topical gene editing are likely to become important. Much of the talk focuses on lasers and other physical modalities: new fractional laser technologies, suction-assisted vascular targeting, selective cryolysis, and the idea of “smart” devices that can image and then precisely treat what they detect. He highlights research on fibrosis, scarring, keloids, itch, melasma, and post-inflammatory hyperpigmentation as major unmet needs that are scientifically tractable. A major example is his work on neurofibromatosis type 1, where combining suction, alexandrite laser, and deoxycholate produced significant tumor reduction without scarring. He also discusses cold-based treatments for fat, nerve block, and congenital nevi, suggesting unexpected clinical applications. Overall, he emphasizes that dermatology has many low-hanging but important problems and that the field should embrace molecular understanding, AI, and device innovation to improve care.
View moreConclusions
- The presentation argues that dermatology is entering a major shift toward molecularly targeted, image-guided, and device-based interventions rather than conventional broad treatments.
- The speaker concludes that lasers and energy devices can be made more selective and practical by combining imaging, suction, and smarter targeting algorithms.
- The work on neurofibromatosis suggests that simple, localized treatments such as alexandrite laser or deoxycholate injection can reduce tumor volume meaningfully with little or no scarring.
- The results imply that selective cryolysis may have broader medical uses beyond fat removal, including prolonged pain and itch modulation through reversible effects on myelin.
- The talk concludes that many currently common skin problems, including melasma and post-inflammatory hyperpigmentation, are still poorly understood but are likely tractable if studied at the molecular level.
- Overall, the speaker is optimistic that the next 1–5 years will bring clinically useful dermatologic innovations that can improve treatment precision, outcomes, and quality of life.
- Richey P, et al. J Am Acad Dermatol. 2024;90(4):767-774.
- Moradi-Tuchayi S, et al. Cryoneurolysis with Injectable Ice Slurry Modulates Mechanical Skin Pain. J Invest Dermatol. 2023;143:134-141.#10.1016/j.jid.2022.07.018
- Elmelegy N, Elghamy S. Carbon Dioxide Cryotherapy for Treatment of Nasal and Perinasal Congenital Melanocytic Nevi. Ann Plast Surg. 2020;85:107-109.#10.1097/sap.0000000000002145